MedTrace Logo

Multi-Ingredient Supplementation in Professional Football Players

NCT07604519 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-22

No results posted yet for this study

Summary

This randomized double-blind placebo-controlled trial will investigate the effects of multi-ingredient supplementation containing taurine, caffeine, and phosphatidylserine on physical performance, cognitive function, cognitive fatigue responses, recovery, sleep quality, and autonomic nervous system activity in elite male soccer players. Participants will complete a 14-day supplementation protocol and undergo football-specific performance, reaction-time, cognitive-fatigue, recovery, and sleep-related assessments before and after the intervention. The study aims to determine whether phosphatidylserine dose influences physical, cognitive, fatigue-related, and recovery-related outcomes when combined with taurine and caffeine.

Conditions

  • Sports Performance
  • Cognitive Performance During Physical Activity
  • Fatigue
  • Recovery
  • Football Players

Interventions

OTHER

Placebo

Placebo capsules administered daily during the 14-day intervention period

DIETARY_SUPPLEMENT

taurine

Taurine supplementation administered daily during the 14-day intervention period.

DIETARY_SUPPLEMENT

Caffeine

Caffeine supplementation administered daily during the 14-day intervention period.

DIETARY_SUPPLEMENT

Phosphatidylserine

Phosphatidylserine supplementation administered daily during the 14-day intervention period.

Sponsors & Collaborators

  • Vizja University in Warsaw

    lead OTHER

Principal Investigators

  • Krzysztof Maciej MIZERA, PhD · 1. Vizja University in Warsaw, Faculty of Medical Sciences and Health Sciences, 01-143 Warsaw, Poland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Hungary
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07604519 on ClinicalTrials.gov